Hypercalcemia is the major electrolyte abnormality in patients with malignant tumors. It can be due to localized osteolytic hypercalcemia or elaboration of humoral substances such as parathyroid hormone-related protein from tumoral cells. In hematological malignancies, a third mechanism of uncontrolled synthesis and secretion of {1-25(OH)2D3} from tumoral cells or neighboring macrophages may contribute to the problem. However, hypercalcemia is quite unusual in patients with B-cell {non-Hodgkin's} lymphoma.
CITATION STYLE
Ghazi, A. A., Attarian, H., Attarian, S., Abasahl, A., Daryani, E., Farasat, E., … Kovacs, K. (2010). Hypercalcemia and huge splenomegaly presenting in an elderly patient with B-cell non-Hodgkin’s lymphoma: a case report. Journal of Medical Case Reports, 4(1). https://doi.org/10.1186/1752-1947-4-330
Mendeley helps you to discover research relevant for your work.